cdmo.directory
← Compare landing

ResolveMass Laboratories Inc. vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/resolvemass/viralgen

CategoryResolveMass Laboratories Inc.Viralgen
Listed sitebothcdmo
SummaryCanadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Analytical Method Development & Validation
  • Medicinal Chemistry
  • US FDA Regulatory Strategy
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • Peptide
  • Small Molecule
  • AAV / Viral Vector Platform
  • Gene Therapy
IndicationsData not yet provided.
  • Rare Disease
Locations
  • Headquarters, Quebec, Quebec, Canada
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • FDA · Identifier: 3042696771
  • ISO · Identifier: ISO 9001:2015
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.